Successful transition to encorafenib following vemurafenib-induced drug rash with eosinophilia and systemic symptoms syndrome. JAAD case reports Young, P. A., Keller, L. C., Bae, G. H. 2021; 9: 42–44

View details for DOI 10.1016/j.jdcr.2020.12.030

View details for PubMedID 33644278